This book covers the introduction, development, and therapeutic applications of animal models for cancer immunotherapy. Each chapter addresses specific models with case studies and are written by highly regarded experts and emerging thought leaders in the field. Together, they summarize current trends and state-of-the-art in the utility of animal models in immunopharmacology and serve as a reference to help pharmacologists identify suitable animal models, design pharmacological or translational studies to advance mechanistic understanding of therapeutic agents, as well as enhance the possibility of success of the novel immunotherapies in the clinic.